Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

People with limited treatment options

HIV salvage regimens can safely omit NRTIs, says US study

News
4 January 2016
New & experimental HIV treatments

HIV Antibody Infusion Safely Suppresses Virus in Infected People

Editor's pick
National Institute of Allergy and Infectious Diseases (NIAID)
24 December 2015
Drug interactions & pharmacokinetics

Many patients on new HCV medications at risk of drug-drug interactions

Editor's pick
Medscape (requires free registration)
23 December 2015
New & experimental HIV treatments

Scientists reveal new phase of HIV infection

Editor's pick
Science Daily
19 December 2015
Pharmaceutical industry

Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare

Editor's pick
Bristol-Myers Squibb press release
18 December 2015
New & experimental HIV treatments

Tenofovir alafenamide fumarate at what price? No more than $1000 a year above existing tenofovir formulation, says model

News
18 December 2015
Treatment simplification strategies

Two-drug ART with dolutegravir-lamivudine would be cost-effective and achieve substantial cash savings

News
17 December 2015
The search for a cure

Sangamo BioSciences Presents Phase 2 Clinical Data From Two SB-728-T HIV Studies

Editor's pick
Sangamo Biosciences press release
14 December 2015
PrEP science

Drug resistance acquired during HIV PrEP rapidly disappears after medication is discontinued

News
14 December 2015
Changing treatment

Study: Protease Inhibitor Monotherapy Does Not Limit Future Treatment Options

Editor's pick
BETA blog
10 December 2015
PrEP

South African Medicines Agency approves PrEP

Editor's pick
South African MCC
8 December 2015
HIV treatment

Top 10 HIV Clinical Developments of 2015

Editor's pick
The Body Pro
8 December 2015
New & experimental HIV treatments

The Medicines Patent Pool Signs a Collaborative Agreement with the University of Liverpool to Develop HIV Nanomedicines

Editor's pick
Medicines Patent Pool
3 December 2015
PrEP

Ipergay PrEP study results published

News
2 December 2015
Retention & linkage to care

WHO issues recommendations on linkage to care, retention, to help bring HIV treatment to all

News
1 December 2015
Treatment guidelines

Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: what’s new

Editor's pick
World Health Organization
1 December 2015
Access to healthcare

Barriers to progress – Treatment activists’ response to WHO HIV treatment guidelines 2015

Editor's pick
International Treatment Preparedness Coalition
1 December 2015
Access to healthcare

Three new agreements announced with the potential to expand access to innovative HIV treatment in low- and middle-income countries

Editor's pick
UNITAID
1 December 2015
Treatment guidelines

Accelerate expansion of antiretroviral therapy to all people living with HIV: WHO

Editor's pick
World Health Organization
1 December 2015
New & experimental HIV treatments

Cipla ready to launch low dose HIV drug efavirenz

Editor's pick
Economic Times
1 December 2015
Access to healthcare

Antiretroviral Drugs Fail to Consistently Reach Patients in Countries Most Affected By HIV/Aids

Editor's pick
MSF press release
30 November 2015
New & experimental HIV treatments

Two-drug maintenance therapy keeps viral load suppressed and may even have advantages over traditional ART

News
30 November 2015
Retention & linkage to care

Dutch research identifies relationship between HIV clinic characteristics and retention of patients in care

News
27 November 2015
Undetectable viral load & treatment as prevention

Can Charlie Sheen really have doctor-approved unprotected sex?

Editor's pick
New York Post
24 November 2015